4//SEC Filing
Degnan Chris 4
Accession 0001209191-19-015811
CIK 0001660334other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:30 PM ET
Size
5.6 KB
Accession
0001209191-19-015811
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-02-28+44,000→ 44,000 totalExercise: $11.32Exp: 2029-02-27→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]25% of shares subject to the option shall vest on February 28, 2020 (the "Initial Vesting Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Initial Vesting Date, subject to the Reporting Person continuing to be a service provider through each such date.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:30 PM ET
- Size
- 5.6 KB